Browse by Author or creator
![[up]](/style/images/multi_up.png)
Up a level2024
Cunningham, Margaret R. and Rattray, Nicholas J.W. and McFadden, Yvonne and Berardi, Domenica and Daramy, Karim and Kelly, Patricia E. and Galbraith, Allison and Lochiel, Isobel and Mills, Lorraine and Scott, Yvonne and Chalmers, Susan and Lannigan, Alison and Rattray, Zahra (2024) Recounting the untold stories of breast cancer patient experiences : lessons learned from a patient-public involvement and engagement (PPIE) storytelling event. International Journal of Pharmacy Practice, 32 (6). riae052. ISSN 2042-7174
2023
Cunningham, Margaret R and Rattray, Nicholas JW and McFadden, Yvonne and Berardi, Domenica and Kelly, Patricia E and Daramy, Karim and Galbraith, Allison and Lochiel, Isobel and Mills, Lorraine and Scott, Yvonne and Chalmers, Susan and Lannigan, Alison and Rattray, Zahra (2023) A roadmap for patient-public involvement and engagement (PPIE) : recounting the untold stories of breast cancer patient experiences. Other. medRxiv, Ithaca, New York.
2022
Abdullah, Mahmud O. and Zeng, Run X. and Margerum, Chelsea L. and Papadopoli, David and Monnin, Cian and Punter, Kaylee B. and Chu, Charles and Al-Rofaidi, Mohammad and Al-Tannak, Naser F. and Berardi, Domenica and Rattray, Zahra and Rattray, Nicholas J.W. and Abraham, Sheela A. and Eskelinen, Eeva-Liisa and Watson, David G. and Avizonis, Daina and Topisirovic, Ivan and Chan, Edmond Y.W. (2022) Mitochondrial hyperfusion via metabolic sensing of regulatory amino acids. Cell Reports, 40 (7). p. 111198. 111198. ISSN 2211-1247
Berardi, Domenica and Hunter, Yasmin and Van Den Driest, Lisa and Farrell, Gillian and Rattray, Nicholas J. W. and Rattray, Zahra (2022) The differential metabolic signature of breast cancer cellular response to olaparib treatment. Cancers, 14 (15). 3661. ISSN 2072-6694
Berardi, Domenica and Hunter, Yasmin and Van Den Driest, Lisa and Rattray, Nicholas and Rattray, Zahra and Farrell, Gillian (2022) The differential metabolic signature of breast cancer cellular response to olaparib treatment. Other. bioRxiv, Cold Spring Harbor.